Alpha Tau Medical Ltd (DRTS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DRTS Annual Balance Sheets →
Tracking balance sheet results across Alpha Tau Medical Ltd to Dec 31 2024 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent12.20
Restricted Investments, Current RE3.78
Short-term Investments, Total60.92
Cash & Short-term Investments75.00
Other Receivables0.04
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.40
Total Current Assets78.30
Equipment/Property/Plant Net5.27
Tax Assets, Noncurrent11.77
Prepaid Expense, Noncurrent, Total PR0.48
Other Assets, Noncurrent9.80
Total Assets105.65
Liabilities
Accounts Payable, Trade, Current3.87
Other Accounts Payable AndAccrued Liabilities3.78
Total Current Liabilities10.51
Long-term debt6.35
Total Long-term Debt6.35
Deferred Tax Liabilities, Gross DE0.10
Other liabilities, Noncurrent14.45
Total Liabilities28.55
Stockholders' Equity
Additional Paid In Capital Common Stock267.24
Retained Earnings / Accumulated Deficit-190.14
Defined Benefit Plan and Other5.35
Other Equity-5.35
Common Stockholder's Equity77.10
Total Stockholder's Equity77.10
Liabilities & Stockholder's Equity105.65
4 historic quarters locked

Sign in to unlock the full Alpha Tau Medical Ltd balance sheet history.

About Alpha Tau Medical Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-025174

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.